Canada markets open in 5 hours 16 minutes

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
91.20-0.86 (-0.93%)
At close: 04:00PM EDT
87.99 -3.21 (-3.52%)
After hours: 07:23PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 17.31B
Enterprise Value 17.33B
Trailing P/E 104.83
Forward P/E 34.01
PEG Ratio (5 yr expected) 0.75
Price/Sales (ttm)7.22
Price/Book (mrq)3.50
Enterprise Value/Revenue 7.16
Enterprise Value/EBITDA 55.96

Trading Information

Stock Price History

Beta (5Y Monthly) 0.32
52-Week Change 3-1.35%
S&P500 52-Week Change 322.64%
52 Week High 399.56
52 Week Low 376.02
50-Day Moving Average 387.78
200-Day Moving Average 389.10

Share Statistics

Avg Vol (3 month) 31.41M
Avg Vol (10 day) 31.61M
Shares Outstanding 5189.78M
Implied Shares Outstanding 6191.52M
Float 8187.23M
% Held by Insiders 10.84%
% Held by Institutions 1100.81%
Shares Short (Mar 28, 2024) 43.06M
Short Ratio (Mar 28, 2024) 42.39
Short % of Float (Mar 28, 2024) 41.63%
Short % of Shares Outstanding (Mar 28, 2024) 41.62%
Shares Short (prior month Feb 29, 2024) 43.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 6.93%
Operating Margin (ttm)4.37%

Management Effectiveness

Return on Assets (ttm)1.63%
Return on Equity (ttm)3.51%

Income Statement

Revenue (ttm)2.42B
Revenue Per Share (ttm)12.88
Quarterly Revenue Growth (yoy)20.20%
Gross Profit (ttm)N/A
EBITDA 276.48M
Net Income Avi to Common (ttm)167.64M
Diluted EPS (ttm)0.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.07B
Total Cash Per Share (mrq)5.69
Total Debt (mrq)1.13B
Total Debt/Equity (mrq)22.90%
Current Ratio (mrq)2.51
Book Value Per Share (mrq)26.25

Cash Flow Statement

Operating Cash Flow (ttm)159.26M
Levered Free Cash Flow (ttm)-25.9M